2Seventy Ebit from 2010 to 2024

TSVT Stock  USD 3.61  0.45  14.24%   
2Seventy Bio EBIT yearly trend continues to be comparatively stable with very little volatility. EBIT will likely drop to about -227.5 M in 2024. From the period from 2010 to 2024, 2Seventy Bio EBIT quarterly data regression had mean square error of 2219.2 T and mean deviation of  39,940,280. View All Fundamentals
 
EBIT  
First Reported
2010-12-31
Previous Quarter
-216.7 M
Current Value
-227.5 M
Quarterly Volatility
52 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check 2Seventy Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 2Seventy Bio's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 10.8 M or Depreciation And Amortization of 10.7 M, as well as many indicators such as Price To Sales Ratio of 1.99, Dividend Yield of 0.0 or PTB Ratio of 0.78. 2Seventy financial statements analysis is a perfect complement when working with 2Seventy Bio Valuation or Volatility modules.
  
Check out the analysis of 2Seventy Bio Correlation against competitors.
For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.

Latest 2Seventy Bio's Ebit Growth Pattern

Below is the plot of the Ebit of 2Seventy Bio over the last few years. It is 2Seventy Bio's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 2Seventy Bio's overall financial position and show how it may be relating to other accounts over time.
Ebit10 Years Trend
Slightly volatile
   Ebit   
       Timeline  

2Seventy Ebit Regression Statistics

Arithmetic Mean(207,556,610)
Coefficient Of Variation(25.07)
Mean Deviation39,940,280
Median(181,264,000)
Standard Deviation52,031,788
Sample Variance2707.3T
Range193.3M
R-Value(0.49)
Mean Square Error2219.2T
R-Squared0.24
Significance0.06
Slope(5,686,104)
Total Sum of Squares37902.3T

2Seventy Ebit History

2024-227.5 M
2023-216.7 M
2022-262.9 M
2021-292.2 M
2020-144.6 M
2019-338 M

Other Fundumenentals of 2Seventy Bio

About 2Seventy Bio Financial Statements

2Seventy Bio shareholders use historical fundamental indicators, such as Ebit, to determine how well the company is positioned to perform in the future. Although 2Seventy Bio investors may analyze each financial statement separately, they are all interrelated. The changes in 2Seventy Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on 2Seventy Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
EBIT-216.7 M-227.5 M
EBITDA-206.4 M-216.7 M
Ebt Per Ebit 1.00  0.75 
Ebit Per Revenue(2.16)(2.27)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for 2Seventy Stock Analysis

When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.